Literature DB >> 7837252

Phenotypic variation of tuberous sclerosis in a single extended kindred.

S L Smalley1, F Burger, M Smith.   

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder with a great degree of phenotypic variability. Given the presence of two gene loci underlying this disorder, locus heterogeneity may account for some of the variability. However, significant within family variation suggests that different genes do not explain the majority of this variation. The purpose of this research is to identify physical and behavioural variation in expression of TSC in a single large extended kindred. TSC in this kindred is cosegregating with markers localised to chromosome 16p13.3. The expression of TSC in this kindred is quite variable with a substantial proportion of persons showing very mild physical expression of TSC. In contrast to very mild physical expression of TSC in some family members, there is a significant clustering of psychiatric disorders among persons affected with TSC compared to their unaffected relatives. This finding, coupled with the mild physical expression of TSC in some family members, supports a hypothesis that the TSC2 gene may present phenotypically as mild skin signs and significant behavioural problems.

Entities:  

Mesh:

Year:  1994        PMID: 7837252      PMCID: PMC1050122          DOI: 10.1136/jmg.31.10.761

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria.

Authors:  M R Gomez
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Genetic heterogeneity in tuberous sclerosis: phenotypic correlations.

Authors:  I M Winship; J M Connor; P H Beighton
Journal:  J Med Genet       Date:  1990-07       Impact factor: 6.318

3.  Diagnostic and genetical aspects of tuberous sclerosis.

Authors:  N C Nevin; W G Pearce
Journal:  J Med Genet       Date:  1968-12       Impact factor: 6.318

4.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

5.  Linkage of the tuberous sclerosis locus to a DNA polymorphism detected by v-abl.

Authors:  J M Connor; L A Pirrit; J R Yates; A E Fryer; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

6.  Assessing psychiatric disorders in children. Discrepancies between mothers' and children's reports.

Authors:  M M Weissman; P Wickramaratne; V Warner; K John; B A Prusoff; K R Merikangas; G D Gammon
Journal:  Arch Gen Psychiatry       Date:  1987-08

7.  Schedule for Affective Disorders and Schizophrenia--Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development.

Authors:  S Mannuzza; A J Fyer; D F Klein; J Endicott
Journal:  J Psychiatr Res       Date:  1986       Impact factor: 4.791

8.  Mapping of a gene determining tuberous sclerosis to human chromosome 11q14-11q23.

Authors:  M Smith; S Smalley; R Cantor; M Pandolfo; M I Gomez; R Baumann; P Flodman; K Yoshiyama; Y Nakamura; C Julier
Journal:  Genomics       Date:  1990-01       Impact factor: 5.736

9.  Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study.

Authors:  I C Gillberg; C Gillberg; G Ahlsén
Journal:  Dev Med Child Neurol       Date:  1994-01       Impact factor: 5.449

10.  Autism diagnostic interview: a standardized investigator-based instrument.

Authors:  A Le Couteur; M Rutter; C Lord; P Rios; S Robertson; M Holdgrafer; J McLennan
Journal:  J Autism Dev Disord       Date:  1989-09
View more
  12 in total

Review 1.  Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex.

Authors:  Petrus J de Vries
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 2.  Specific genetic disorders and autism: clinical contribution towards their identification.

Authors:  David Cohen; Nadège Pichard; Sylvie Tordjman; Clarisse Baumann; Lydie Burglen; Elsa Excoffier; Gabriela Lazar; Philippe Mazet; Clément Pinquier; Alain Verloes; Delphine Héron
Journal:  J Autism Dev Disord       Date:  2005-02

Review 3.  Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis.

Authors:  Petrus de Vries; Ayla Humphrey; Deborah McCartney; Penny Prather; Patrick Bolton; Ann Hunt
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-07       Impact factor: 4.785

4.  Autism in tuberous sclerosis complex.

Authors:  G C Gutierrez; S L Smalley; P E Tanguay
Journal:  J Autism Dev Disord       Date:  1998-04

5.  Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin.

Authors:  Itzamarie Chévere-Torres; Jordan M Maki; Emanuela Santini; Eric Klann
Journal:  Neurobiol Dis       Date:  2011-07-30       Impact factor: 5.996

6.  Tuberous sclerosis complex; single center experience.

Authors:  İlknur Erol; Tülin Savaş; Sevda Şekerci; Nalan Yazıcı; Ayşe Erbay; Şenay Demir; Semra Saygı; Özlem Alkan
Journal:  Turk Pediatri Ars       Date:  2015-03-01

7.  The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families.

Authors:  Petrus J de Vries; Ann Hunt; Patrick F Bolton
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-01-31       Impact factor: 4.785

8.  Identification of a nonsense mutation at the 5' end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex.

Authors:  R Vrtel; S Verhoef; K Bouman; M M Maheshwar; M Nellist; A J van Essen; P L Bakker; C J Hermans; M T Bink-Boelkens; R M van Elburg; M Hoff; D Lindhout; J Sampson; D J Halley; A M van den Ouweland
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

Review 9.  Autism and tuberous sclerosis.

Authors:  S L Smalley
Journal:  J Autism Dev Disord       Date:  1998-10

10.  Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients.

Authors:  Sandra L Dabora; Penelope Roberts; Andres Nieto; Ron Perez; Sergiusz Jozwiak; David Franz; John Bissler; Elizabeth A Thiele; Katherine Sims; David J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2002-08-21       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.